Search Results - "Pieruzzi, F."

Refine Results
  1. 1
  2. 2

    Redefining the Pulvinar Sign in Fabry Disease by Cocozza, S, Russo, C, Pisani, A, Olivo, G, Riccio, E, Cervo, A, Pontillo, G, Feriozzi, S, Veroux, M, Battaglia, Y, Concolino, D, Pieruzzi, F, Mignani, R, Borrelli, P, Imbriaco, M, Brunetti, A, Tedeschi, E, Palma, G

    Published in American journal of neuroradiology : AJNR (01-12-2017)
    “…The pulvinar sign refers to exclusive T1WI hyperintensity of the lateral pulvinar. Long considered a common sign of Fabry disease, the pulvinar sign has been…”
    Get full text
    Journal Article
  3. 3

    Intrafamilial phenotypic variability in four families with Anderson-Fabry disease by Rigoldi, M., Concolino, D., Morrone, A., Pieruzzi, F., Ravaglia, R., Furlan, F., Santus, F., Strisciuglio, P., Torti, G., Parini, R.

    Published in Clinical genetics (01-09-2014)
    “…We analysed the clinical history of 16 hemizygous males affected by Anderson‐Fabry Disease, from four families, to verify their intrafamilial phenotypic…”
    Get full text
    Journal Article
  4. 4

    La denervazione renale transcatetere: il ruolo del nefrologo by Pieruzzi, F.

    Published in Giornale di clinica nefrologica e dialisi (26-01-2018)
    “…Studi clinici recenti hanno dimostrato che la denervazione renale bilaterale con catetere a radiofrequenza riduce significativamente i valori pressori…”
    Get full text
    Journal Article
  5. 5

    Atrial fibrillation in end stage renal disease patients: influence of hemodialysis on P wave duration and atrial dimension by Genovesi, S., Fabbrini, P., Pieruzzi, F., Galbiati, E., Sironi, E., Pogliani, D., Bonforte, G., Viganò, M. R., Stella, A.

    Published in Journal of nephrology (01-10-2015)
    “…Background Prevalence and incidence of atrial fibrillation (AF) are high in hemodialysis (HD) patients. Intra-atrial conduction velocity slowing plays an…”
    Get full text
    Journal Article
  6. 6

    Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties by Fabbrini, P, Sirtori, S, Casiraghi, E, Pieruzzi, F, Genovesi, S, Corti, D, Brivio, R, Gregorini, G, Como, G, Carati, M L, Viganò, M R, Stella, A

    Published in Blood purification (01-01-2013)
    “…Polymethylmethacrylate (PMMA) membranes can adsorb a wide variety of uremic toxins including serum free light chains (sFLC). However, limited data are…”
    Get more information
    Journal Article
  7. 7

    Functional capacity and gender-related differences in Fabry disease by Guglielmi, G, Mollo, A, Bandera, F, Camporeale, A, Frigelli, M, Alfonzetti, E, Lombardi, M, Pieroni, M, Pieruzzi, F, Guazzi, M

    Published in European heart journal (12-10-2021)
    “…Abstract Background Fabry disease (FD) is a rare x-linked lysosomal storage disease characterized by accumulation of glicosphingolipids in several organs,…”
    Get full text
    Journal Article
  8. 8

    Effect of migalastat on cardiac involvement in Fabry disease: preliminary results from MAIORA study by Camporeale, A, Bandera, F, Pieroni, M, Pieruzzi, F, Bersano, A, Econimo, L, Lanzillo, C, Limongelli, G, Mignani, R, Motta, I, Olivotto, I, Milani, V, Guazzi, M, Lombardi, M

    Published in European heart journal (12-10-2021)
    “…Abstract Background Fabry Disease (FD) is a rare X-linked lysosomal storage disorder. Since 2016, pharmacological chaperone Migalastat has been approved for…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Progressive electrocardiographic changes in parallel with cardiac magnetic resonance findings in fabry disease by Figliozzi, S, Camporeale, A, Pieroni, M, Pieruzzi, F, Namdar, M, Lusardi, P, Spada, M, Mignani, R, Burlina, A, Scolari, F, Carrubbi, F, Battaglia, Y, Graziani, F, Boveri, S, Lombardi, M

    Published in European heart journal (01-11-2020)
    “…Abstract Background Cardiac Magnetic Resonance (CMR) allows to detect progressive stages of cardiac involvement in Fabry Disease (FD). A systematic description…”
    Get full text
    Journal Article
  11. 11

    Left atrial morpho-functional changes in hypertrophic cardiomyopathy and Fabry disease: a CMR-feature tracking study by Moroni, A, Tondi, L, Camporeale, A, Milani, V, Pica, S, Pieroni, M, Pieruzzi, F, Ferri, L, Arosio, R, Chow, K, Lombardi, M

    “…Abstract Funding Acknowledgements Type of funding sources: None. Background Left ventricular (LV) diastolic dysfunction (DD) is a hallmark of hypertrophic…”
    Get full text
    Journal Article
  12. 12

    Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial by Geetha, Duvuru, Dua, Anisha, Yue, Huibin, Springer, Jason, Salvarani, Carlo, Jayne, David, Merkel, Peter

    Published in Annals of the rheumatic diseases (01-02-2024)
    “…To evaluate the efficacy and safety of avacopan in the subgroup of patients with antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis receiving…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan by Bruchfeld, Annette, Bekker, Pirow, Luxton, G., Ranganathan, D., Lhotta, K., Hellemans, R., Hougardy, J., Sprangers, B., Wissing, K., Pagnoux, C., Barbour, S., Brachemi, S., Becvar, R., Gregersen, J., Lyngsoe, C., Rigothier, C., Karras, A., Klein, A., Maurier, F., Moranne, O., Schaier, M., Grundmann, F., Haller, H., Haubitz, M., Henes, J., Hohenstein, B., Iking-Konert, C., Kubacki, T., Kotter, I., Halbritter, J., Mehling, H., Venhoff, N., Brunetta, E., Dagna, L., Emmi, G., Manenti, L., Atsumi, T., Kaneko, Y., Katagiri, A., Kirino, Y., Kitagawa, K., Komatsuda, A., Kono, H., Kurasawa, T., Matsumura, R., Morinobu, A., Nanki, T., Oshima, H., Sada, K., Tamura, N., Tsukamoto, T., Rutgers, A., Walker, R., Collins, M., de Zoysa, J., Kalstad, S., Clarkson, M., Ciggaran, S., Oliveras, X. Fulladosa, Rusinol, H. Marco, Segarra, A., Westman, K., Burnier, M., Daikeler, T., Hauser, T., Seeger, H., Vogt, B., Amin, T., Brogan, P., Dasgupta, B., Doulton, T., Flossmann, O., Griffin, S., Klocke, R., Lanyon, P., McLaren, J., Makanjuola, D., Selvan, S., O'Riordan, E., Pusey, C., Robson, J., Robson, M., Sznajd, J., Taylor, J., Belilos, E., Chen Lin, Y. Chang, Dragoi, S., Dua, A., Geetha, D., Kivitz, A., Koening, C., Langford, C., Mohamed, A., Monach, P., Parks, D., Sam, R., Striebich, C., Swarup, A., Thakar, S., Wasko, M. Chester

    Published in Kidney international reports (01-04-2023)
    “…In the 330-patient ADVOCATE trial of avacopan for the treatment of antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis, in which 81% of…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Results of blood pressure screening in a population of school-aged children in the province of Milan : role of overweight by GENOVESI, Simonetta, GIUSSANI, Marco, PIERUZZI, Federico, VIGORITA, Federico, ARCOVIO, Claudia, CAVUTO, Silvio, STELLA, Andrea

    Published in Journal of hypertension (01-03-2005)
    “…To study the prevalence of high blood pressure (BP) in an Italian paediatric population, and to verify whether in this population elevated BP values are…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20